Profil
Rebekah de Vitry Fries currently works at DiaMedica Therapeutics, Inc., as Vice President-Clinical Operations from 2024.
Ms. de Vitry Fries also formerly worked at Marinus Pharmaceuticals, Inc., as Director-Clinical Development Operations and Epygenix Therapeutics, Inc., as Head-Clinical Operations.
Ms. de Vitry Fries received her undergraduate degree from Rochester Institute of Technology.
Postes actifs de Rebekah de Vitry Fries
| Sociétés | Poste | Début |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 20/02/2024 |
Anciens postes connus de Rebekah de Vitry Fries
| Sociétés | Poste | Fin |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Corporate Officer/Principal | - |
Formation de Rebekah de Vitry Fries
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Rochester Institute of Technology
Rochester Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
















